SCHEMBL25952183

SCHEMBL25952183

c1ccc(-c2cccc(-c3ccc(-c4nc(-c5ccc6c(c5)oc5ccc(-c7ccc8c(c7)sc7ccccc78)cc56)nc(-c5cccc6c5sc5ccccc56)n4)cc3)c2)cc1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PRKDC P78527 6/20 0.40
ALOX5 P09917 1/20 0.38
LIMK1 P53667 6/20 0.36
LIMK2 P53671 1/20 0.33
PLA2G2A P14555 2/20 0.33
PLA2G4A P47712 2/20 0.33
PLA2G10 O15496 1/20 0.33
PIK3CD O00329 2/20 0.32
PIK3CB P42338 2/20 0.32
PIM3 Q86V86 2/20 0.32
PIM1 P11309 1/20 0.32
CSNK2A2 P19784 1/20 0.32
CSNK2B P67870 1/20 0.32
PIM2 Q9P1W9 1/20 0.32
BRD4 O60885 1/20 0.31
PIK3CA P42336 1/20 0.31
MTOR P42345 1/20 0.31
PIK3CG P48736 1/20 0.31
KCNH2 Q12809 1/20 0.31
BRDT Q58F21 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24264197 0.98 PRKDC (0.41) PRKDCALOX5LIMK1LIMK2PLA2G2A
SCHEMBL24318007 0.96 PRKDC (0.41) PRKDCALOX5LIMK1LIMK2PLA2G2A
SCHEMBL25627444 0.96 PRKDC (0.43) PRKDCALOX5LIMK1PLA2G2APLA2G4A
SCHEMBL24217295 0.96 PRKDC (0.43) PRKDCALOX5LIMK1PLA2G2APLA2G4A
SCHEMBL25627155 0.96 PRKDC (0.43) PRKDCALOX5LIMK1PLA2G2APLA2G4A
SCHEMBL25627449 0.96 PRKDC (0.43) PRKDCALOX5LIMK1PLA2G2APLA2G4A
SCHEMBL21784867 0.95 PRKDC (0.41) PRKDCALOX5LIMK1PLA2G2APLA2G4A
SCHEMBL24264272 0.94 PRKDC (0.41) PRKDCALOX5LIMK1PLA2G2APLA2G4A
SCHEMBL24264112 0.94 PRKDC (0.43) PRKDCALOX5LIMK1PLA2G2APLA2G4A
SCHEMBL24264255 0.94 PRKDC (0.43) PRKDCALOX5LIMK1PLA2G2APLA2G4A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230312538-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME LT MATERIALS CO., LTD. (KR) 2023-10-05 US disclosed
US-20230312538-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME LT MATERIALS CO., LTD. (KR) 2023-10-05 US disclosed
EP-4212526-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME LT Materials Co., Ltd. (KR) 2023-07-19 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230312538-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME CRY1, CYP1A1, CYP1B1 PRKDC 4577/4885ALOX5 579/4885LIMK1 279/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.